Difference between revisions of "Pyruvate kinase"

From ISMOC
Jump to: navigation, search
(Parameters with uncertainty)
(Parameters with uncertainty)
 
Line 82: Line 82:
  
 
<imagemap>
 
<imagemap>
Image:Allosteric_L_val.png|frameless|center|alt=Allosteric L Value
+
Image:Allosteric_L_val.png|frameless|center|600px|alt=Allosteric L Value
 
</imagemap>
 
</imagemap>
  

Latest revision as of 15:30, 26 May 2015

Pyruvate kinase is a transferase enzyme that catalyzes the transfer of a phosphate group from phosphoenolpyruvate (PEP) to ADP, yielding one molecule of pyruvate and one molecule of ATP.

Chemical reaction

 PEP + ADP \rightleftharpoons Pyrvate + ATP

Rate equation

The rate equation is represented by the allosteric regualation model of Monod, Wyman and Changeux (MWS). Fru1,6BP and Serine are activators and ATP is inhibiting. Simple Micahelis-Menten kinetics (Briggs Haldane) is used for ADP and reverse reaction [1]

v=V_m \left( \left(\frac{\frac{[ADP]}{K_{ADP}}}{1+\frac{[ADP]}{K_{ADP}}}\right) \left( \frac{\frac{[PEP]}{Km_{PEP}}\left( 1+\frac{[PEP]}{Km_{PEP}}  \right)^3 }{ \frac{L \left( 1 + \frac{[ATP]}{Ki_{ATP}} \right)^4 }{ \left( 1 + \frac{[SER]}{Ka_{SER}} \right)^4 \left(  1 + \frac{F1,6BP}{Ka_{F1,6BP}} \right)^4  } + \left( 1 + \frac{[PEP]}{Km_{PEP}} \right)^4} \right) - \left( \frac{\frac{[ATP][PYR]}{K_{ATP} \times K_{PYR} \times K_{eq}}}{1 +\frac{[ATP]}{K_{ATP}} + \frac{[PYR]}{K_{PYR}} + \frac{[ATP][PYR]}{K_{ATP} \times K_{PYR} }} \right)  \right)

Parameter values

  • The dissociation constant is commonly used to describe the affinity between a ligand (L) (such as a drug) and a protein (P) i.e. how tightly a ligand binds to a particular protein. In the specific case of antibodies (Ab) binding to antigen (Ag), usually the affinity constant is used. It is the inverted dissociation constant.

K_{a} = \frac{1}{K_{d}}
Parameter Value Units Organism Remarks
V_{mf} 1.9[2]  \text{mM min}^{-1} HeLa cell line
K_{eq}[2] 195172 Recalculated from the ΔGº´ = - 31.4 KJ mol-1.
Km_{PEP}[2] 0.014 mM
Km_{ADP}[2] 0.4 mM
Km_{PYR}[3] 10 mM
Km_{ATP}[3] 0.86 mM
Ka_{F1,6BP}[4] 4\times 10^{-4} mM
Ki_{ATP}[4] 2.5 mM
L[5] 1 Dimensionless
Ka_{SER} 5 mM For allosteric regulation the affinity constant is used. It is the inverted dissociation constant. so  Ka_{SER} = \frac{1}{K_d} where  k_d = 0.2 mM [6]

Parameters with uncertainty

  • Three values of Ki_{ATP} have been reported as 0.14 mM, 0.12 mM, 0.33 mM in Boyer et. al. (1969) [7]. However, he also cited papers that describe the Ki value between 3.5 mM and 1.0 mM. Hernandez et. al. reported a value of 2.5 mM. Considering all these factors we consider the vlaue to lie in between 3.5mM and 1.0 mM. Taking these three values of 1.0, 2.5, 3.5 we have the Mean and Std. Dev. as 2.33 \pm 1.25.
  • Four isoforms of PYK exists. Among those four, three isoforms (R, L and M2) exhibits cooperative kinetics activated by Fru1,6BP (Ka = 0.00006 - 0.0004). For calculating the mean and standard deviation we consider max = 0.0004 and min = 0.00006. The range rule tells that the mean of a sample is the average of the maximum and the minimum value and standard deviation is approximately equal to one fourth of the range of the data ie. s = (Maximum – Minimum)/4. So the mean is (0.0004 + 0.00006)/2= 0.00023 and std. dev. = 0.000085[8].
  • Four values for Km_{PYR} found in the literature are 0.025,0.055 [9] for Sparus aurata liver, 0.48 for Selenomonas ruminantium [10] and 10 [3]. The mean and std. dev. from these 4 values are 2.64 and 4.9.
  • Two values of Km_{ATP} have been reported in the literature. 0.35 for Sparus aurata liver [9] and 0.86 [3]. The uncertainty is then 0.60 \pm 0.36.
  • Two values of Serine activation for Pyruvate Kinase constant have been reported; 2[11] and 5 [6]. Taking mean and Std. Dev. for this two value gives 3.5 \pm 2.12.
  • Del valle (1986) [12] determined the Allosteric Constant L with the effect of L-alanine and Furctose1,6BP. For L-alanine the value of L is reported to be 3200 \pm 275 whereas in the presence of 100 \mu M Fru1,6BP the value is reported as 2.3. As in our model we do not consider the affect of L-alaine but consder only the effect of Fru1,6BP we took this value of 2.3. But there is no uncertainty reported with this value. So we took the same proportion of uncertainty as that of L-alaine for this value. This gives the value as 2.3 \pm 0.184
Allosteric L Value
About this image
  • The K_{eq} values found in the literature are ΔGº´ = -23.0 | -31.4 | -24.98 | -26.815 kJ/mol, =>Keq = 10753.64 | 318061.48 | 16190 | 32995
  • Hernandez reported the value of Km_{PEP} as 0.014 in [2]. But there is not Std. Dev. mentioned with the data. So we calculate the Std. Dev. based on the same maximum ratio of other kinetic parameters Std. Dev. which is for parameter Km_{PYR}. Considering this ratio of error the value for Km_{PEP} is 0.014 \pm 0.0262.
Parameter Value Units Organism Remarks
V_{mf} 3 \pm 1.3 (4)[13]
195 \pm 84.5 [2]
U\cdot(\text{mg protein})^{-1}
mM\cdot(min)^{-1}
HeLa cell line
K_{eq}[2] 117558.7 \pm 173764.13
Km_{PEP} 0.014 \pm 0.0262[14] mM
Km_{ADP} 0.24 \pm 0.03[14] mM
Km_{PYR} 2.64 \pm 4.9 mM
Km_{ATP} 0.60 \pm 0.36 mM
Ka_{F1,6BP} 0.00023 \pm 0.000085 mM
Ki_{ATP} 2.33 \pm 1.25[7] mM
L 2.3 \pm 0.184[12] Dimensionless
Ka_{SER} 3.5 \pm 2.12 mM

Equilibrium constant

Equilibrium constant Conditions Source
318061.48 pH=7, T=25°C Lehninger, (2008)[15] p 553:

\Delta G' = -31.4\ kJ.mol^{-1}, Keq = exp(-\frac{\Delta G'}{RT}) = exp(\frac{31400}{8.31*298.15}) \approx 318061.48

10753.64 pH=7, T=25°C \Delta G' = -23.0\ kJ.mol^{-1}, Keq = exp(-\frac{\Delta G'}{RT}) = exp(\frac{23000}{8.31*298.15}) \approx 10753.64
23860.98 pH=7, T=25°C \Delta G' = -24.98\ kJ.mol^{-1}, Keq = exp(-\frac{\Delta G'}{RT}) = exp(\frac{23000}{8.31*298.15}) \approx 23860.98
  • Averaging these values gives 117558.7 \pm 173764.13

References

  1. Monod J, Wyman J, Changeux J-P (1965). On the Nature of Allosteric Transitions: A Plausible Model . Journal of Molecular Biology 12:88–118 (doi)
  2. 2.0 2.1 2.2 2.3 2.4 2.5 2.6 Marín-Hernández A, Gallardo-Pérez JC, Rodríguez-Enríquez S et al (2011) Modeling cancer glycolysis. Biochim Biophys Acta 1807:755–767 (doi)
  3. 3.0 3.1 3.2 3.3 H.U. Bergmeyer. Methods of Enzymatic Analysis. Verlag Chemie, Winheim
  4. 4.0 4.1 Imamura K, Tanaka T (1982). Pyruvate kinase isoenzymes from rat, Methods Enzymol. 90 (1982) 150–165
  5. Arbitrary value
  6. 6.0 6.1 Chaneton, B. et al.(2012) Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature 491, 458–462
  7. 7.0 7.1 P.D. Boyer (1969, The inhibition of pyruvate kinase by ATP: A Mg++ buffer system for use in enzyme studies, Biochemical and Biophysical Research Communications, Volume 34, Issue 5, 10 March 1969, Pages 702–706
  8. A. Marín-Hernández, J.C. Gallardo-Pérez, S.J. Ralph, S. Rodríguez-Enríquez, R. Moreno-Sánchez (2009), HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms, Mini Rev. Med. Chem., 9, pp. 1084–1101
  9. 9.0 9.1 Gomez-Milan E., Cardenete G., Sanchez-Muros M.J. (2007), Annual variations in the specific activity of fructose 1,6-bisphosphatase, alanine aminotransferase and pyruvate kinase in the Sparus aurata liver, Comp. Biochem. Physiol. B 147, 49-55
  10. Asanuma N., Hino T. (2001), Molecular characterization, enzyme properties and transcriptional regulation of phosphoenolpyruvate carboxykinase and pyruvate kinase in a ruminal bacterium, Selenomonas ruminantium, Microbiology 147, 681-690 (2001)
  11. M.J. Merrins, A.R. Van Dyke, A.K. Mapp, M.A. Rizzo, L.S. Satin (2013), Direct measurements of oscillatory glycolysis in pancreatic islet beta-cells using novel fluorescence resonance energy transfer (FRET) biosensors for pyruvate kinase M2 activity. J. Biol. Chem. 288, 33312–33322
  12. 12.0 12.1 del Valle,P.,de Arriaga, D., Busto, F. and Soler, J. (1986) A study of the allosteric kinetics of Phycomyces pyruvate kinase as judged by the effect of e-alanine and fructose 1,6-bisphosphate. Biochim. Biophys. Acta 874, 193-204
  13. Marín-Hernández A , Rodríguez-Enríquez S, Vital-González P A, et al. (2006). Determining and understanding the control of glycolysis in fast-growth tumor cells. Flux control by an over-expressed but strongly product-inhibited hexokinase. FEBS J., 273 , pp. 1975–1988(doi)
  14. 14.0 14.1 Dombrauckas, J. D., Santarsiero, B. D. & Mesecar, A. D. (2005) Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry 44, 9417–9429
  15. David L. Nelson, Michael M. Cox (2008), Lehninger Principles of Biochemistry (5th edn), W. H. Freeman and Company